M12.27
Villonodular synovitis (pigmented), ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Villonodular synovitis, also known as pigmented villonodular synovitis (PVNS), is a rare joint disorder characterized by abnormal growth of the synovial membrane — the soft tissue lining joints. When it affects the ankle and foot, it can lead to pain, swelling, and reduced movement. Although it is benign, PVNS can be aggressive and may recur after treatment if not fully addressed. Understanding this condition helps in recognizing its symptoms and the importance of medical intervention.
Causes & Symptoms
Clinical Causes: The exact cause of pigmented villonodular synovitis remains unknown. Researchers believe it may involve abnormal cell growth within the synovial tissue, possibly triggered by an inflammatory process or genetic factors. PVNS is not caused by infections or injury, but joint trauma might sometimes precede symptoms, though it is not considered a direct cause.
Key Symptoms: Persistent swelling around the affected joint Localized joint pain, which may worsen with activity Stiffness and reduced range of motion A sensation of catching or locking within the joint A feeling of instability or weakness in the ankle or foot Recurrent episodes of joint effusion (fluid buildup) In some cases, warmth and tenderness around the joint
Diagnostic & Treatment
Diagnosis Path: Patient history review and physical examination to assess swelling, tenderness, and range of motion Imaging studies, primarily magnetic resonance imaging (MRI), which provides detailed visualization of synovial tissue and can identify characteristic pigmented deposits and tissue growth X-rays may be used to rule out other joint conditions and assess for bone involvement Arthroscopy, a minimally invasive procedure that allows direct visualization of the joint and tissue sampling for histopathological analysis Biopsy of affected tissue to confirm PVNS through microscopic examination
Treatment Protocols: Synovectomy: Surgical removal of the affected synovial membrane, aiming to eliminate abnormal tissue and minimize recurrence Arthroscopic surgery, which is minimally invasive and often preferred for its quicker recovery time In some cases, open surgery may be necessary if the disease is extensive Postoperative physiotherapy to restore joint function and strength Regular follow-up imaging to detect potential recurrence early In rare cases, adjuvant radiotherapy may be considered to reduce the risk of regrowth Medications are generally not used as a primary treatment but may be part of research protocols
Clinical Advice & FAQs
Billing Guidance
Is M12.27 a billable ICD-10 code?
Yes, M12.27 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M12.27?
Clinical documentation must specify the nature of Villonodular synovitis (pigmented), ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference